Терапевтический архив (Jul 2009)

Pilot experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary skin involvement. A case report

  • Varvara Ivanovna Zamyatina,
  • Aminat Umaraskhabovna Magomedova,
  • Sergey Kirillovich Kravchenko,
  • Elena Aleksandrovna Gilyazitdinova,
  • Elena Alekseevna Ilyushkina,
  • Evgeniy Evgen'evich Zvonkov,
  • Irina Borisovna Kaplanskaya,
  • Tat'yana Nikiforovna Obukhova,
  • Galina Aleksandrovna Klyasova,
  • Lana Anzorovna Gorgidze,
  • Zhanna Valentinovna Churakova,
  • Aleksandra Mikhaylovna Kremenetskaya,
  • Andrey Ivanovich Vorob'ev,
  • V I Zamyatina,
  • A U Magomedova,
  • S K Kravchenko,
  • E A Gilyazitdinova,
  • E A Ilyushkina,
  • E E Zvonkov,
  • I B Kaplanskaya,
  • T N Obukhova,
  • G A Klyasova,
  • L A Gorgidze,
  • Zh V Churakova,
  • A M Kremenetskaya,
  • A I Vorobyev

Journal volume & issue
Vol. 81, no. 7
pp. 71 – 75

Abstract

Read online

Primary skin large B-cell lymphosarcomas (PLBCL) present with skin lesions, other organs and systems are not involved. As CHOP courses are not high effective in PLBCL, we were the first to treat a patient with modified block therapy NHL BFM-90. A complete remission was achieved after the first course of polychemotherapy and was consolidated by two courses of treatment. Further follow-up is needed.

Keywords